Abstract
NSAID-induced gastrointestinal mucosal injury and its subsequent complications are a tremendously important clinical problem. Effective prophylactic and treatment strategies involve proton pump inhibitors, misoprostol, or selective COX-2 inhibitors. These agents are capable of dramatically decreasing or eliminating the risk of mucosal injury as well as the morbidity and mortality for this disorder. Identification of the at-risk patient and initiation of appropriate preventive therapy are the keys to minimizing the societal burden of this disease process.
Original language | English (US) |
---|---|
Pages (from-to) | 87-88, 91-94 |
Journal | Postgraduate medicine |
Volume | 110 |
Issue number | 3 |
DOIs | |
State | Published - 2001 |
ASJC Scopus subject areas
- Medicine(all)